12P.P.GotP.P. i inni, Production and characterization of 22 monoclonal antibodies directed against S 20499, a new potent 5-HT1A chiral agonist: influence of the hapten structure on specificity and stereorecognition, „Pharmaceutical Research”, 16 (5), 1999, s. 725–735, DOI:10.1023/a:1018832810105, PMID:10350017(ang.).
12G.G.GriebelG.G. i inni, Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice, „Neuroreport”, 3 (1), 1992, s. 84–86, DOI:10.1097/00001756-199201000-00022, PMID:1351756(ang.).
↑P.P.SimonP.P., B.B.GuardiolaB.B., J.J.Bizot-EspiardJ.J., P.P.SchiaviP.P., J.J.CostentinJ.J., 5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists, „Psychopharmacology”, 108 (1–2), 1992, s. 47–50, DOI:10.1007/BF02245284, PMID:1357709(ang.).
↑BernadetteB.AstierBernadetteB. i inni, In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity, „European Journal of Pharmacology”, 459 (1), 2003, s. 17–26, DOI:10.1016/s0014-2999(02)02814-5, PMID:12505530(ang.).